Wealth Manager - the site for professional investment managers

Register to get unlimited access to all of Citywire’s Fund Manager database. Registration is free and only takes a minute.

Overnight Markets: US stocks dip as investors wary before jobs report

Overnight Markets: US stocks dip as investors wary before jobs report

Wall Street fell on Thursday as investors turned cautious ahead of Friday's monthly jobs report, while consumer and technology shares declined.

The Dow Jones industrial average closed little changed at 16,573, after hitting an intraday record of 16,604. The S&P 500 slipped two points or 0.11%, to finish at 1,889. It also hit an intraday record high of 1,894. The Nasdaq Composite declined 39 points or 0.91%, to end at 4,238.

Investors were cautious and avoided big bets ahead of Friday's nonfarm payrolls report. Economists expect that employers added 200,000 jobs to nonfarm payrolls in March, according to a Reuters poll.

On the economic front, the US trade deficit unexpectedly widened in February to $42.3 billion as exports hit a five-month low, suggesting that first-quarter growth could be much weaker than initially expected.

In the services sector, growth accelerated in March after being hampered by unusually cold weather, according to the Institute for Supply Management's services-sector index.

In corporate news, Tesla Motors (TSLA.O), the electric car maker, declined 2.1% and the shares of Netflix Inc (NFLX.O), the online movie rental company, lost 2.3%. Facebook (FB.O) shares fell 5.2%.

Anadarko Petroleum Corp (APC.N) shares jumped 14.5% following news that the company will pay $5.15 billion to settle years of litigation over pollution clean-up claims related to uranium deposits, wood creosote and rocket fuel processing.

Shares of Barnes & Noble Inc (BKS.N) fell 13.5% after Liberty Media Corp (LMCA.O) said it has sold almost all of its stake in the company.

In the biopharmaceutical sector, Gilead Sciences Inc (GILD.O) edged up 0.1% after it said late Wednesday that a trial of its hepatitis C drug sofosbuvir, sold under the brand name Sovaldi in the US, showed the drug was safe and effective.

In Asia, shares oscillated between gains and losses on Friday in morning trade amid low trading volume as investors await data on US jobs growth.

The MSCI Asia Pacific Index slid 0.1% to 139 as of 9:36 a.m. in Hong Kong. Japan’s Topix index slid 0.1% on Friday. Australia’s S&P/ASX 200 Index slipped 0.1%, while New Zealand’s NZX 50 Index declined 0.1%. South Korea’s Kospi index retreated 0.2%. Hong Kong’s Hang Seng Index slid 0.4%.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Navigating geopolitical risk with ETFs

Navigating geopolitical risk with ETFs

ETFGI’s Deborah Fuhr on how investors can use exchange-traded funds to position their portfolio.

Play Sarasin’s Boucher: why I like salmon with chocolate

Sarasin’s Boucher: why I like salmon with chocolate

Henry Boucher, manager of the £129 million Sarasin Food & Agriculture Opportunities fund, explains why he is gobbling up salmon and chocolate stocks.

Play Alibaba hype, the UK slowdown and opportunities in European sovereign bonds

Alibaba hype, the UK slowdown and opportunities in European sovereign bonds

Libby Ashby and leading wealth managers analyse what the Alibaba IPO hype means for Chinese equities, slowing growth of the UK economy and whether there’s anything left to play for in the European sovereign bond market.

Your Business: Cover Star Club

Profile: Barclays' former advisory boss on his move into property

Profile: Barclays' former advisory boss on his move into property

On paper, Rick Denton might have been expected to finish his career in banking

Wealth Manager on Twitter